Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|June 8, 2007
Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actionsG G Yarbrough, J Kamath, A Winokur, et al.
Pharmacology & Therapeutics|November 13, 2008
The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesisJ Kamath, G G Yarbrough, A J Prange, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
Prospective strategies for cholinergic interventions in Alzheimer's diseaseN Pomara, C A Bagne, M Stanley, et al.
The Journal of International Medical Research|September 19, 2009
Thyrotropin-releasing hormone can relieve cancer-related fatigue: hypothesis and preliminary observationsJ Kamath, G G Yarbrough, A J Prange, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1983
Pharmacological characterization of purinergic receptors in the rat vas deferensD A Taylor, S Wiese, E P Faison, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1983
Spontaneously hypertensive rats exhibit an enhanced mydriatic response to clonidine. Evidence for enhanced sensitivity of central alpha 2-adrenoceptorsG G Yarbrough, D A Taylor, E K Antolik, et al.
Journal of Medicinal Chemistry|February 1, 1982
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonistY Girard, J G Atkinson, D R Haubrich, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1984
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO]G E Martin, M Williams, D J Pettibone, et al.
Life Sciences|May 24, 1982
Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE)G E Martin, M Williams, B V Clineschmidt, et al.
European Journal of Pharmacology|March 16, 1984
Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by a series of dopamine agonistsG G Yarbrough, J McGuffin-Clineschmidt, D K Singh, et al.
Pageof 4